Peter Turčáni

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial

Ashkan Shoamanesh, Hardi Mundl, Eric E. Smith et al. · The Lancet · 2022 · 193 citations · Full text

Medicine, Neurology, Pharmacology +11

Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage

Jennifer Diedler, André Rupp, Peter Turčáni et al. · Critical Care Medicine · 2008 · 122 citations

Medicine, Neurology, Hemodynamic Management +16

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Impaired Baroreceptor Reflex Sensitivity in Acute Stroke Is Associated With Insular Involvement, But Not With Carotid Atherosclerosis

Jennifer Diedler, André Rupp, Peter Turčáni et al. · Stroke · 2009 · 85 citations

Medicine, Neurology, Neuroscience +15